{"stages":[{"name":"landscapes","label":"Landscapes","icon":"&#x1f5fa;","color":"#4fc3f7","table":"landscape_analyses","total":3,"delta_7d":0,"throughput_pct":100.0,"oldest_unprocessed":null,"sla_days":7,"stuck_description":"No linked gap after 7 days","stuck":[],"list_url":"/senate/pipeline/stage/landscapes"},{"name":"gaps","label":"Gaps","icon":"&#x1f50d;","color":"#ffb74d","table":"knowledge_gaps","total":3545,"delta_7d":0,"throughput_pct":0.9,"oldest_unprocessed":"2026-04-01T20:45:05-07:00","sla_days":30,"stuck_description":"status=open/proposed, never debated after 30 days","stuck":[{"id":"gap-test-20260425-224949","title":"Test","status":"open","priority_score":0.9,"composite_score":null,"created_at":"2026-04-25T22:49:49.848121-07:00","debate_count":0,"last_debated_at":null},{"id":"gap-pubmed-20260410-192446-e28cf8c6","title":"What is the diagnostic specificity and sensitivity of motor band sign on 18F-FDG PET/CT for MNDs?","status":"open","priority_score":0.87,"composite_score":null,"created_at":"2026-04-10T19:24:46.958106-07:00","debate_count":0,"last_debated_at":null},{"id":"gap-pubmed-20260411-072403-f896e08f","title":"Will the cognitive benefits of JAK inhibition in HAND translate from mouse models to HIV-positive humans on cART?","status":"open","priority_score":0.87,"composite_score":null,"created_at":"2026-04-11T07:24:03.476634-07:00","debate_count":0,"last_debated_at":null},{"id":"gap-pubmed-20260410-150438-b037602a","title":"How does calcium dysregulation at synapses contribute to AD and PD synaptopathy?","status":"open","priority_score":0.86,"composite_score":null,"created_at":"2026-04-10T15:04:38.519084-07:00","debate_count":0,"last_debated_at":null},{"id":"gap-pubmed-20260410-180503-26b108e7","title":"Should tau-targeted therapies be redesigned to account for Aβ-tau synergy rather than targeting tau alone?","status":"open","priority_score":0.86,"composite_score":null,"created_at":"2026-04-10T18:05:03.484932-07:00","debate_count":0,"last_debated_at":null},{"id":"gap-pubmed-20260410-183201-e5534f58","title":"How do specific microbial metabolites affect CNS cell function during neuroinflammatory conditions?","status":"open","priority_score":0.86,"composite_score":null,"created_at":"2026-04-10T18:32:01.352413-07:00","debate_count":0,"last_debated_at":null},{"id":"gap-pubmed-20260410-184203-136029e2","title":"How do UCH-mediated ubiquitination imbalances differentially drive cancer versus neurodegeneration?","status":"open","priority_score":0.86,"composite_score":null,"created_at":"2026-04-10T18:42:03.105471-07:00","debate_count":0,"last_debated_at":null},{"id":"gap-pubmed-20260410-185251-a2373bc1","title":"How do roscovitine and tamoxifen's different mechanisms both effectively reduce Cdk5 levels in AD?","status":"open","priority_score":0.86,"composite_score":null,"created_at":"2026-04-10T18:52:51.698472-07:00","debate_count":0,"last_debated_at":null},{"id":"gap-pubmed-20260410-191933-4ee24fe1","title":"How does gastrointestinal inflammation causally contribute to alpha-synuclein pathology and dopaminergic neuronal loss?","status":"open","priority_score":0.86,"composite_score":null,"created_at":"2026-04-10T19:19:33.994157-07:00","debate_count":0,"last_debated_at":null},{"id":"gap-pubmed-20260411-070434-a4efc962","title":"How can glymphatic imaging biomarkers be validated for diagnostic use in neurodegenerative diseases?","status":"open","priority_score":0.86,"composite_score":null,"created_at":"2026-04-11T07:04:34.344342-07:00","debate_count":0,"last_debated_at":null}],"list_url":"/senate/pipeline/stage/gaps"},{"name":"debates","label":"Debates","icon":"&#x1f5e3;","color":"#ce93d8","table":"debate_sessions","total":915,"delta_7d":0,"throughput_pct":51.1,"oldest_unprocessed":"2026-04-02T00:31:42.392597-07:00","sla_days":3,"stuck_description":"Debate generated 0 hypotheses after 3 days","stuck":[{"id":"sess_SDA-2026-04-02-gap-20260402-003058","question":"Is disrupted sleep a cause or consequence of neurodegeneration? Analyze the bidirectional relationship between sleep disorders (particularly circadian rhythm disruption and impaired glymphatic clearance) and neurodegenerative disease progression, focusing on amyloid-beta accumulation, tau pathology, and the therapeutic potential of sleep restoration interventions.","quality_score":0.46,"num_hypotheses_generated":0,"status":"completed","created_at":"2026-04-02T00:31:42.392597-07:00","analysis_id":"SDA-2026-04-02-gap-20260402-003058"},{"id":"sess_SDA-2026-04-02-gap-20260402-003115","question":"Is disrupted sleep a cause or consequence of neurodegeneration? Analyze the bidirectional relationship between sleep disorders (particularly circadian rhythm disruption and impaired glymphatic clearance) and neurodegenerative disease progression, focusing on amyloid-beta accumulation, tau pathology, and the therapeutic potential of sleep restoration interventions.","quality_score":0.59,"num_hypotheses_generated":0,"status":"completed","created_at":"2026-04-02T00:32:45.316709-07:00","analysis_id":"SDA-2026-04-02-gap-20260402-003115"},{"id":"sess_SDA-2026-04-02-gap-microglial-subtypes-20260402004119","question":"Analyze the spectrum of microglial activation states (DAM, homeostatic, inflammatory) and their distinct roles in AD, PD, and ALS. Identify pharmacological targets for shifting microglia toward protective phenotypes.","quality_score":0.49,"num_hypotheses_generated":0,"status":"completed","created_at":"2026-04-02T00:45:41.300763-07:00","analysis_id":"SDA-2026-04-02-gap-microglial-subtypes-20260402004119"},{"id":"sess_SDA-2026-04-02-gap-aging-mouse-brain-v2-20260402","question":"What gene expression changes in the aging mouse brain predict neurodegenerative vulnerability? Use Allen Aging Mouse Brain Atlas data. Cross-reference with human AD datasets. Produce hypotheses about aging-neurodegeneration mechanisms.","quality_score":0.57,"num_hypotheses_generated":0,"status":"completed","created_at":"2026-04-02T02:50:58.381614-07:00","analysis_id":"SDA-2026-04-02-gap-aging-mouse-brain-v2-20260402"},{"id":"sess_SDA-2026-04-02-gap-aging-mouse-brain-v3-20260402","question":"What gene expression changes in the aging mouse brain predict neurodegenerative vulnerability? Use Allen Aging Mouse Brain Atlas data. Cross-reference with human AD datasets. Produce hypotheses about aging-neurodegeneration mechanisms.","quality_score":0.5,"num_hypotheses_generated":0,"status":"completed","created_at":"2026-04-02T02:55:24.361088-07:00","analysis_id":"SDA-2026-04-02-gap-aging-mouse-brain-v3-20260402"},{"id":"sess_SDA-2026-04-02-gap-seaad-20260402025452","question":"What cell types are most vulnerable in Alzheimers Disease based on SEA-AD transcriptomic data? Use Allen Brain Cell Atlas evidence. Identify mechanisms of cell-type-specific vulnerability in AD pathology.","quality_score":0.56,"num_hypotheses_generated":0,"status":"completed","created_at":"2026-04-02T02:55:59.602610-07:00","analysis_id":"SDA-2026-04-02-gap-seaad-20260402025452"},{"id":"sess_SDA-2026-04-02-gap-aging-mouse-brain-v4-20260402","question":"What gene expression changes in the aging mouse brain predict neurodegenerative vulnerability? Use Allen Aging Mouse Brain Atlas data. Cross-reference with human AD datasets. Produce hypotheses about aging-neurodegeneration mechanisms.","quality_score":0.43,"num_hypotheses_generated":0,"status":"completed","created_at":"2026-04-02T02:59:27.954382-07:00","analysis_id":"SDA-2026-04-02-gap-aging-mouse-brain-v4-20260402"},{"id":"sess_SDA-2026-04-02-26abc5e5f9f2","question":"Analyze circuit-level changes in neurodegeneration using Allen Institute Neural Dynamics data. Focus on: (1) hippocampal circuit disruption, (2) cortical dynamics alterations, (3) sensory processing changes. Identify circuit-based therapeutic targets connecting genes, proteins, and brain regions to neurodegeneration phenotypes.","quality_score":0.42,"num_hypotheses_generated":0,"status":"completed","created_at":"2026-04-02T03:01:41.943540-07:00","analysis_id":"SDA-2026-04-02-26abc5e5f9f2"},{"id":"sess_SDA-2026-04-02-gap-immune-atlas-neuroinflam-20260402","question":"Comprehensive analysis of immune cell subtypes in neurodegeneration: microglia subtypes (DAM, homeostatic, inflammatory), astrocyte reactivity states, T-cell infiltration. Anchor to existing TREM2 (h-b234254c, h-044ee057) and complement cascade hypotheses (h-58e4635a, h-1fe4ba9b, h-5a55aabc). Produce inflammatory pathway diagrams and generate 3-5 new hypotheses connecting immune findings to disease mechanisms.","quality_score":0.55,"num_hypotheses_generated":0,"status":"completed","created_at":"2026-04-02T03:03:30.826691-07:00","analysis_id":"SDA-2026-04-02-gap-immune-atlas-neuroinflam-20260402"},{"id":"sess_SDA-2026-04-02-gap-seaad-v3-20260402063622","question":"What cell types are most vulnerable in Alzheimers Disease based on SEA-AD transcriptomic data from the Allen Brain Cell Atlas? Identify mechanisms of cell-type-specific vulnerability in neurons, microglia, astrocytes, and oligodendrocytes. Focus on gene expression patterns, pathway dysregulation, and therapeutic implications. Use evidence from the Seattle Alzheimers Disease Brain Cell Atlas.","quality_score":0.57,"num_hypotheses_generated":0,"status":"completed","created_at":"2026-04-02T06:50:55.777806-07:00","analysis_id":"SDA-2026-04-02-gap-seaad-v3-20260402063622"}],"list_url":"/senate/pipeline/stage/debates"},{"name":"hypotheses","label":"Hypotheses","icon":"&#x1f9ec;","color":"#81c784","table":"hypotheses","total":2408,"delta_7d":0,"throughput_pct":57.6,"oldest_unprocessed":"2026-04-02T07:45:17-07:00","sla_days":14,"stuck_description":"composite_score < 0.5 after 14 days","stuck":[{"id":"h-2e7eb2ea","title":"Enteric Nervous System Prion-Like Propagation Blockade","composite_score":0.48,"confidence_score":0.5,"target_gene":"TLR4, SNCA","status":"archived","created_at":"2026-04-02T07:45:17-07:00","analysis_id":"SDA-2026-04-01-gap-20260401-225155"},{"id":"h-f9c6fa3f","title":"Microbiome-Derived Tryptophan Metabolite Neuroprotection","composite_score":0.427,"confidence_score":0.3,"target_gene":"AHR, IL10, TGFB1","status":"archived","created_at":"2026-04-02T07:45:17-07:00","analysis_id":"SDA-2026-04-01-gap-20260401-225155"},{"id":"h-7bb47d7a","title":"Bacterial Enzyme-Mediated Dopamine Precursor Synthesis","composite_score":0.384,"confidence_score":0.2,"target_gene":"TH, AADC","status":"archived","created_at":"2026-04-02T07:45:17-07:00","analysis_id":"SDA-2026-04-01-gap-20260401-225155"},{"id":"h-d78123d1","title":"Microglia-Derived Extracellular Vesicle Engineering for Targeted Mitochondrial Delivery","composite_score":0.482,"confidence_score":0.3,"target_gene":"RAB27A/LAMP2B","status":"archived","created_at":"2026-04-02T20:53:40-07:00","analysis_id":"SDA-2026-04-01-gap-20260401231108"},{"id":"h-8bd89d90","title":"Prohibitin-2 Mitochondrial Cross-Seeding Hub Disruption","composite_score":0.469,"confidence_score":0.45,"target_gene":"PHB2","status":"archived","created_at":"2026-04-02T20:53:40-07:00","analysis_id":"SDA-2026-04-01-gap-9137255b"},{"id":"h-7693c291","title":"RNA-Binding Competition Therapy for TDP-43 Cross-Seeding","composite_score":0.465,"confidence_score":0.4,"target_gene":"TARDBP","status":"archived","created_at":"2026-04-02T20:53:40-07:00","analysis_id":"SDA-2026-04-01-gap-9137255b"},{"id":"h-9adb5c9e","title":"Gap Junction Hemichannel Modulation for Controlled Mitochondrial Exchange","composite_score":0.36130000000000007,"confidence_score":0.4,"target_gene":"PANX1","status":"archived","created_at":"2026-04-02T20:53:40-07:00","analysis_id":"SDA-2026-04-01-gap-20260401231108"},{"id":"h-826df660","title":"Optogenetic Control of Mitochondrial Transfer Networks","composite_score":0.476,"confidence_score":0.4,"target_gene":"ChR2","status":"archived","created_at":"2026-04-02T20:53:40-07:00","analysis_id":"SDA-2026-04-01-gap-20260401231108"},{"id":"hyp_test_f15ab6d9","title":"Test: TREM2 enhances amyloid clearance","composite_score":0.4,"confidence_score":0.3,"target_gene":"TREM2","status":"archived","created_at":"2026-04-04T05:28:01-07:00","analysis_id":"test-hypothesis-fixtures-v1"},{"id":"h-a11f71b5","title":"Conditional CRISPR Kill Switches for Aberrant Protein Clearance","composite_score":0.4965,"confidence_score":0.3,"target_gene":"UBE3A, PARK2, PINK1","status":"archived","created_at":"2026-04-04T13:38:52-07:00","analysis_id":"SDA-2026-04-03-gap-crispr-neurodegeneration-20260402"}],"list_url":"/senate/pipeline/stage/hypotheses"},{"name":"ranked","label":"Ranked","icon":"&#x1f3c6;","color":"#ffd54f","table":"hypotheses (score≥0.5)","total":1388,"delta_7d":0,"throughput_pct":26.3,"oldest_unprocessed":"2026-04-02T01:01:46.338884-07:00","sla_days":30,"stuck_description":"Ranked hypothesis not linked to any challenge after 30 days","stuck":[{"id":"h-var-1a15a9a02f","title":"HSP90-cochaperone complexes preferentially stabilize intermediate misfolded states preceding amyloid formation","composite_score":0.84,"target_gene":"HSP90AA1, HSP90AB1, STIP1, AHSA1","status":"validated","created_at":"2026-04-28T11:49:30.921627-07:00"},{"id":"h-var-ff24f8f76f","title":"J-protein substrate specificity codes enable HSP70 discrimination of β-sheet versus α-helical misfolded conformers","composite_score":0.84,"target_gene":"DNAJB6","status":"validated","created_at":"2026-04-28T11:49:41.057750-07:00"},{"id":"h-var-002f522b52","title":"Activity-Dependent CD55/CD46 Trafficking and Synaptic Surface Localization","composite_score":0.8332,"target_gene":"CD55 (DAF), CD46 (MCP)","status":"validated","created_at":"2026-04-28T11:49:59.844641-07:00"},{"id":"h-var-92a02b86a1","title":"CREB-Dependent Differential Complement Regulator Positioning for Activity-Based Synaptic Vulnerability Control","composite_score":0.8332,"target_gene":"CREB1, CD55, CD46","status":"validated","created_at":"2026-04-28T11:50:08.166018-07:00"},{"id":"h-var-1843e5134a","title":"J-protein co-chaperone system mediates selective autophagy targeting of pathogenic protein aggregates","composite_score":0.8308,"target_gene":"DNAJB6, DNAJB2, HSPA8, HSPA1A, MAP1LC3B, ATG7","status":"validated","created_at":"2026-04-28T11:49:51.130117-07:00"},{"id":"h-cross-synth-tdp43-rna-proteostasis","title":"TDP-43 RNA-proteostasis failure across ALS, FTD, and AD/LATE","composite_score":0.828,"target_gene":"TARDBP","status":"validated","created_at":"2026-04-28T12:40:55.537635-07:00"},{"id":"h-620a7b5b79","title":"Gamma entrainment repairs cross-regional phase-amplitude coupling via CA1 Schaffer collateral plasticity","composite_score":0.8260000000000001,"target_gene":"GRIN2A/GRIN2B (NR2A/NR2B NMDA receptors), CAMK2A","status":"validated","created_at":"2026-04-28T12:49:22.019299-07:00"},{"id":"h-cross-synth-snca-synucleinopathy","title":"SNCA conformer propagation across PD, DLB, and MSA","composite_score":0.82,"target_gene":"SNCA","status":"validated","created_at":"2026-04-28T12:40:58.623457-07:00"},{"id":"h-b007ca967f","title":"Autophagy-Lysosomal Pathway Dysfunction as a Unifying Proteostasis Failure","composite_score":0.82,"target_gene":"TFEB, GBA1, VPS35, TMEM175","status":"validated","created_at":"2026-04-28T12:57:27.294387-07:00"},{"id":"h-var-32c4875adb","title":"CYP46A1 Small Molecule Activator Therapy","composite_score":0.8194,"target_gene":"CYP46A1","status":"validated","created_at":"2026-04-28T11:56:02.850079-07:00"}],"list_url":"/senate/pipeline/stage/ranked"},{"name":"challenges","label":"Challenges / Experiments","icon":"&#x1f3af;","color":"#ef5350","table":"challenges (276) + experiments (724)","total":1000,"total_challenges":276,"total_experiments":724,"delta_7d":0,"throughput_pct":10.9,"oldest_unprocessed":"2026-04-03T20:25:03-07:00","sla_days":45,"stuck_description":"Open challenge with no linked experiment after 45 days","stuck":[{"id":"ch-bbb-antibody-008","title":"Engineering Improved Blood-Brain Barrier Penetrance for Antibody Therapeutics in Neurodegeneration","status":"open","current_bounty_usd":5008097.399999999,"composite_score":0.89,"created_at":"2026-04-17T12:45:28-07:00","scope":"gap","challenge_type":"open"},{"id":"ch-tdp43-phase-006","title":"Therapeutic Targeting of TDP-43 Phase Separation in ALS-FTD","status":"open","current_bounty_usd":4005598.5,"composite_score":0.84,"created_at":"2026-04-17T13:58:01.760800-07:00","scope":"gap","challenge_type":"open"},{"id":"ch-apoe4-targeting-010","title":"Therapeutic Correction of APOE4 Structure and Function in Alzheimer's Disease","status":"open","current_bounty_usd":3501753.8,"composite_score":0.83,"created_at":"2026-04-17T13:58:01.760800-07:00","scope":"gap","challenge_type":"open"},{"id":"ch-epigenetic-circuit-015","title":"Nutrient-Sensing Epigenetic Circuit Reactivation to Restore Neuronal Resilience","status":"open","current_bounty_usd":3204451.9,"composite_score":0.84,"created_at":"2026-04-17T13:58:01.760800-07:00","scope":"gap","challenge_type":"open"},{"id":"ch-gba-synuclein-002","title":"Breaking the GBA—α-Synuclein Bidirectional Feedback Loop in Parkinson's Disease","status":"open","current_bounty_usd":3002638.8,"composite_score":0.82,"created_at":"2026-04-17T13:58:01.760800-07:00","scope":"gap","challenge_type":"open"},{"id":"ch-senolytic-013","title":"Senolytic Therapy for Age-Related Neurodegeneration: Target Cell Selectivity and CNS Delivery","status":"open","current_bounty_usd":2800000.0,"composite_score":0.8,"created_at":"2026-04-17T13:58:01.760800-07:00","scope":"gap","challenge_type":"open"},{"id":"ch-ferroptosis-microglia-016","title":"ACSL4-Driven Ferroptosis in Disease-Associated Microglia: Therapeutic Opportunity in AD","status":"open","current_bounty_usd":2600000.0,"composite_score":0.8,"created_at":"2026-04-17T13:58:01.760800-07:00","scope":"gap","challenge_type":"open"},{"id":"ch-trem2-dam-001","title":"TREM2 Agonism vs Antagonism in Disease-Associated Microglia","status":"open","current_bounty_usd":2500000.0,"composite_score":0.81,"created_at":"2026-04-17T13:58:01.760800-07:00","scope":"gap","challenge_type":"open"},{"id":"ch-autophagy-lysosome-011","title":"Convergent Autophagy-Lysosome Pathway Therapeutics Across Neurodegenerative Diseases","status":"open","current_bounty_usd":2200000.0,"composite_score":0.8,"created_at":"2026-04-17T13:58:01.760800-07:00","scope":"gap","challenge_type":"open"},{"id":"ch-microglia-astrocyte-009","title":"Characterizing and Interrupting Microglia-Astrocyte Neuroinflammatory Amplification Loops","status":"open","current_bounty_usd":2000000.0,"composite_score":0.78,"created_at":"2026-04-17T13:58:01.760800-07:00","scope":"gap","challenge_type":"open"}],"list_url":"/senate/pipeline/stage/challenges"}],"generated_at":"2026-06-17T16:16:42.280091+00:00"}